On November 27, the Shanghai Municipal Science and Technology Commission released the seventh batch of its prestigious "New and Superior Pharmaceutical and Medical Device" product catalog. The UR8000 Coagulation Analyzer, independently developed by Shanghai Sun Biotech Co., Ltd., was successfully selected.
This catalog highlights innovative products with outstanding clinical value and technology reaching international or domestic leading levels, supporting Shanghai's goal of becoming a globally influential biopharmaceutical hub. Designed to meet world-class standards, the UR8000 delivers exceptional high-speed, consistent performance to meet the high-throughput demands of large clinical laboratories.
Consistent 900 Tests/Hour — Global First
The UR8000 is the world's first ultra-high-speed coagulation analyzer, delivering a consistent throughput of 900 tests/hour for PT, APTT, TT, Fibrinogen, and D-Dimer, with a comprehensive capacity of 180 samples/hour. Compared to mainstream products, D-Dimer testing efficiency improves by 350%, and overall five-parameter efficiency increases by 260%, significantly reducing turnaround time.

Intelligent HIL Detection with Multi-Wavelength Interference Management
The UR8000 features an intelligent HIL (Hemolysis, Icterus, Lipemia) monitoring system that precisely identifies and automatically grades interference levels in samples. With four detection wavelengths, the system intelligently selects the optimal wavelength based on HIL results, effectively avoiding abnormal absorption peaks and minimizing analytical interference.

Closed-Tube Sampling for Enhanced Biosafety with Continuous Reagent Loading
The UR8000 comes standard with closed-tube cap-piercing sampling, eliminating manual decapping and preventing aerosol dispersion for superior biosafety. Its dual detection system design enables continuous reagent and consumable loading without interrupting testing operations.

Seamless Automation Line Integration
The UR8000 integrates with the UL-2000LAS Automated Sample Processing System to create a customized coagulation automation line, achieving full automation from pre-analytical processing through final testing.

This selection into the "New and Superior Medical Device" catalog represents authoritative recognition of the UR8000's technological innovation and clinical value. Shanghai Sun Biotechnology remains committed to advancing thrombosis and hemostasis diagnostics, responding to clinical needs through independent innovation and serving global health with Chinese ingenuity.